Ticlopidine
Back to searchMolecule Structure
Scientific Name
Ticlopidine
Description of the Drug
Ticlopidine is a platelet aggregation inhibitor used in the prevention of conditions associated with thrombi, such as stroke and transient ischemic attacks (TIA).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00208
http://www.drugbank.ca/drugs/DB00208
Brand Name(s)
Not Available
Company Owner(s)
Roche Palo Alto Llc, Apotex Inc, Teva Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Chartwell Rx Sciences Llc, Actavis Elizabeth Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Purinergic receptor P2Y12 | SINGLE PROTEIN | ANTAGONIST | CHEMBL2001 |
Clinical Trial(s)
Unichem Links
| Atlas | ticlopidine | ||
| SureChEMBL | SCHEMBL4204 | ||
| PharmGKB | PA451686 | ||
| Human Metabolome Database | HMDB0014353 | ||
| DrugBank | DB00208 | ||
| PubChem: Thomson Pharma | 15197138 | ||
| PubChem | 5472 | ||
| Mcule | MCULE-3971692083 | ||
| LINCS | LSM-1986 | ||
| Nikkaji | J11.390E | ||
| PDBe | TIC | ||
| BindingDB | 85509 | ||
| EPA CompTox Dashboard | DTXSID5023669 | ||
| DrugCentral | 2657 | ||
| Brenda | 155123 | ||
| ChemicalBook | CB7674370 | ||
| Guide to Pharmacology | 7307 | ||
| rxnorm | TICLID | TICLOPIDINE | TICLOPIDINE HYDROCHLORIDE |
| KEGG Ligand | C07140 | ||
| ChEBI | 9588 | ||
| ZINC | ZINC000019594599 |
